Standard BioTools ROA 2010-2025 | LAB
Current and historical return on assets (ROA) values for Standard BioTools (LAB) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Standard BioTools ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2025-03-31 |
$-0.13B |
$0.58B |
-20.60% |
| 2024-12-31 |
$-0.19B |
$0.61B |
-26.61% |
| 2024-09-30 |
$-0.17B |
$0.68B |
-27.45% |
| 2024-06-30 |
$-0.17B |
$0.71B |
-30.71% |
| 2024-03-31 |
$-0.14B |
$0.78B |
-30.29% |
| 2023-12-31 |
$-0.08B |
$0.32B |
-21.58% |
| 2023-09-30 |
$-0.08B |
$0.34B |
-20.86% |
| 2023-06-30 |
$-0.08B |
$0.36B |
-21.92% |
| 2023-03-31 |
$-0.13B |
$0.37B |
-32.39% |
| 2022-12-31 |
$-0.19B |
$0.39B |
-50.07% |
| 2022-09-30 |
$-0.18B |
$0.42B |
-50.75% |
| 2022-06-30 |
$-0.16B |
$0.44B |
-51.34% |
| 2022-03-31 |
$-0.12B |
$0.27B |
-41.50% |
| 2021-12-31 |
$-0.06B |
$0.28B |
-20.50% |
| 2021-09-30 |
$-0.07B |
$0.28B |
-22.65% |
| 2021-06-30 |
$-0.06B |
$0.29B |
-19.32% |
| 2021-03-31 |
$-0.06B |
$0.31B |
-18.14% |
| 2020-12-31 |
$-0.05B |
$0.33B |
-17.38% |
| 2020-09-30 |
$-0.05B |
$0.32B |
-16.55% |
| 2020-06-30 |
$-0.06B |
$0.28B |
-19.89% |
| 2020-03-31 |
$-0.06B |
$0.29B |
-20.22% |
| 2019-12-31 |
$-0.07B |
$0.27B |
-23.44% |
| 2019-09-30 |
$-0.07B |
$0.27B |
-23.34% |
| 2019-06-30 |
$-0.07B |
$0.28B |
-24.40% |
| 2019-03-31 |
$-0.07B |
$0.29B |
-25.68% |
| 2018-12-31 |
$-0.06B |
$0.30B |
-21.75% |
| 2018-09-30 |
$-0.05B |
$0.25B |
-20.22% |
| 2018-06-30 |
$-0.06B |
$0.26B |
-19.86% |
| 2018-03-31 |
$-0.06B |
$0.27B |
-19.86% |
| 2017-12-31 |
$-0.06B |
$0.29B |
-20.87% |
| 2017-09-30 |
$-0.07B |
$0.29B |
-23.27% |
| 2017-06-30 |
$-0.07B |
$0.28B |
-24.06% |
| 2017-03-31 |
$-0.07B |
$0.29B |
-23.49% |
| 2016-12-31 |
$-0.08B |
$0.31B |
-23.30% |
| 2016-09-30 |
$-0.07B |
$0.32B |
-20.78% |
| 2016-06-30 |
$-0.06B |
$0.34B |
-16.90% |
| 2016-03-31 |
$-0.06B |
$0.35B |
-15.29% |
| 2015-12-31 |
$-0.05B |
$0.37B |
-13.84% |
| 2015-09-30 |
$-0.05B |
$0.38B |
-12.99% |
| 2015-06-30 |
$-0.06B |
$0.39B |
-13.98% |
| 2015-03-31 |
$-0.05B |
$0.40B |
-13.24% |
| 2014-12-31 |
$-0.05B |
$0.41B |
-12.76% |
| 2014-09-30 |
$-0.05B |
$0.41B |
-13.72% |
| 2014-06-30 |
$-0.04B |
$0.42B |
-13.78% |
| 2014-03-31 |
$-0.03B |
$0.43B |
-14.58% |
| 2013-12-31 |
$-0.02B |
$0.12B |
-14.91% |
| 2013-09-30 |
$-0.02B |
$0.11B |
-14.13% |
| 2013-06-30 |
$-0.02B |
$0.11B |
-14.04% |
| 2013-03-31 |
$-0.02B |
$0.11B |
-16.63% |
| 2012-12-31 |
$-0.02B |
$0.11B |
-21.80% |
| 2012-09-30 |
$-0.02B |
$0.12B |
-22.89% |
| 2012-06-30 |
$-0.02B |
$0.07B |
-25.50% |
| 2012-03-31 |
$-0.02B |
$0.07B |
-26.33% |
| 2011-12-31 |
$-0.03B |
$0.08B |
-36.15% |
| 2011-09-30 |
$-0.03B |
$0.08B |
-42.91% |
| 2011-06-30 |
$-0.03B |
$0.09B |
-52.63% |
| 2011-03-31 |
$-0.03B |
$0.10B |
-78.87% |
| 2010-12-31 |
$-0.02B |
$0.03B |
-144.68% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Information Systems |
$0.384B |
$0.174B |
|
Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif.
|
